Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Joel Gelfand, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States
IPC Board Member

Joel M. Gelfand MD MSCE is a James J. Leyden Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 260 scientific publications, editorials, reviews, and textbook chapters (cited over 18,000 times, H index 60) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s New Investigator Marjorie Bowman Award and the Lady Barbara Colyton’s Award for Autoimmune research, Penn’s Department of Biostatistics and Epidemiology’s epidemiology teaching award, NPF’s inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture and the American Academy of Dermatology’s Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Last Updated: Jan 31, 2022



Kevin Cooper, MD
University Hospitals of Cleveland
Cleveland, Ohio, United States

Kevin D. Cooper, M.D., is Chair of the Department of Dermatology at University Hospitals Case Medical Center. He is the Director of the department's Skin Diseases Research Center, and Professor of Oncology and Pathology at the Case School of Medicine. Dr. Cooper has been a staff physician at the Ann Arbor (Michigan) and Cleveland VA Medical Centers for 20 years. He attended college and medical school at the University of Florida and completed his residency training and a fellowship at the Oregon Health Sciences University, Oregon. He then became a senior fellow at the Dermatology Branch of the National Cancer Institute, one of the National Institutes of Health, and progressed from Assistant Professor to Professor of Dermatology at the University of Michigan prior to his move to Cleveland. Dr. Cooper is the past president of the Society for Investigative Dermatology (2004-2005), the world's leading organization for scientific communication and advancement in cutaneous biology and dermatology.

Last Updated: Sep 20, 2014

Alexander Navarini, MD, PhD
University Hospital of Basel
Basel, Switzerland

Alexander Navarini is chairman of the Department of Dermatology, University Hospital of Basel since 2018. He was elected professor of immunodermatology, deputy head of the outpatient clinic and head of the patch testing laboratory at the University of Zurich, as well as leading the clinics for hand eczema and work-related dermatology, psoriasis and acne. Prof. Alexander Navarini graduated from medical school at the University of Basel and Université Marie-Curie in Paris, France in 2002. Between 2003 and 2006 he completed a postgraduate course in Experimental Medicine and Biology and MD Ph.D. studies at the University of Zurich. His research focuses on next generation genetics and gene hunting, as well as visual detection of skin diseases. He has published over 130 peer-reviewed articles and several bookchapters. Alexander Navarini is currently Principal Investigator of the European Rare and Severe Psoriasis Network (ERASPEN) for harmonizing phenotype descriptions, as well as of several clinical trials and the Swiss psoriasis registry.

Last Updated: Mar 26, 2019

Nick Reynolds, BSc, MBBS, MD, FRCP
Newcastle University
Newcastle Upon Tyne, England, United Kingdom

Professor Nick J Reynolds received his dermatology training in Bristol, Ann Arbor, Michigan USA and Newcastle upon Tyne. He was appointed to the Chair of Dermatology, Newcastle University and Honorary Consultant Dermatologist, Royal Victoria Infirmary, Newcastle upon Tyne in 2001. Nick leads a dynamic interdisciplinary research group in Newcastle and his clinical and research interests are focused on inflammatory skin disease (psoriasis and atopic eczema). He was previously Chair of the Research and Steering Committees, British Association of Dermatologists Biologics Registry (BADBIR), Chair of UK TREND (Translational Research Network in Dermatology) and President of the European Society for Dermatological Research (ESDR). In 2019, Nick was selected as a NIHR Senior Investigator and is currently Secretary General and Vice President of the European Dermatology Forum (EDF).

Last Updated: Jul 23, 2021

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.